Transfusion of one unit or more of Rh-positive red blood cells normally causes circulating anti-D antibody to appear 2-6 months later in 80-95% of Rh persons. We asked whether transplant immunosuppression with cyclosporine and corticosteroids affects Rh immuniza¬tion. Nineteen Rh" liver, heart, and heart-lung transplant recipients received 3—153 (median: 10) units of Rh+ RBCs at surgery and were tested for anti-D >2 months later. Three patients developed anti-D at 11—15 days; one may have had an unusually rapid primary immune response and two were secondary to previous exposure by pregnancy. None of the other 16 patients had anti-D when tested 2.5-51 months later (13 patients, >11.5 months). This low rate of Rhesus immunization in associati...
The focus of transfusion services is now shifting toward the prevention of alloimmunization and dela...
Background: The Rh blood group system is the most polymorphic of the human blood groups and is the m...
Because of the liver graft's ability to resist cytotoxic antibody-mediated rejection, it has become ...
Matching for Rhesus (Rh) blood group is not part of organ allocation systems. The principle concern ...
Liver transplant patients frequently require large amounts of blood. The frequency and nature of the...
Background: In transfusion practice we should respect the ABO group and the Rh phenotype. The lack o...
Rhesus (Rh) alloimmunization is potentially devastating for reproductive health. Rarely, RhD mismatc...
Background/Case Studies: D negative (D-) patients (pts) are routinely transfused with D-RBCs due to ...
Background & objectives: The number of blood components required during a liver-transplant surgery i...
Background Anti-RhD immunised donors provide anti-RhD immunoglobulins used for the prevention of rhe...
Clinicians sometimes are confronted with the challenge of transfusing haemorrhaging Rhesus (Rh) D ne...
BACKGROUND:Anti-RhD immunised donors provide anti-RhD immunoglobulins used for the prevention of rhe...
Blood transfusions are given to increase oxygen-carrying capacity and intravascular volume. Despite ...
Background Platelet concentrates (PC) contain residual contaminating red blood cells (RBC), being...
Six hundred sixty-seven first, second, and third orthotopic liver allografts in 520 patients were re...
The focus of transfusion services is now shifting toward the prevention of alloimmunization and dela...
Background: The Rh blood group system is the most polymorphic of the human blood groups and is the m...
Because of the liver graft's ability to resist cytotoxic antibody-mediated rejection, it has become ...
Matching for Rhesus (Rh) blood group is not part of organ allocation systems. The principle concern ...
Liver transplant patients frequently require large amounts of blood. The frequency and nature of the...
Background: In transfusion practice we should respect the ABO group and the Rh phenotype. The lack o...
Rhesus (Rh) alloimmunization is potentially devastating for reproductive health. Rarely, RhD mismatc...
Background/Case Studies: D negative (D-) patients (pts) are routinely transfused with D-RBCs due to ...
Background & objectives: The number of blood components required during a liver-transplant surgery i...
Background Anti-RhD immunised donors provide anti-RhD immunoglobulins used for the prevention of rhe...
Clinicians sometimes are confronted with the challenge of transfusing haemorrhaging Rhesus (Rh) D ne...
BACKGROUND:Anti-RhD immunised donors provide anti-RhD immunoglobulins used for the prevention of rhe...
Blood transfusions are given to increase oxygen-carrying capacity and intravascular volume. Despite ...
Background Platelet concentrates (PC) contain residual contaminating red blood cells (RBC), being...
Six hundred sixty-seven first, second, and third orthotopic liver allografts in 520 patients were re...
The focus of transfusion services is now shifting toward the prevention of alloimmunization and dela...
Background: The Rh blood group system is the most polymorphic of the human blood groups and is the m...
Because of the liver graft's ability to resist cytotoxic antibody-mediated rejection, it has become ...